Anusha Gunasekera

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

Sumana Chakravarty, Stephen L. Hoffman, S. Hoffman, 2010, Human vaccines.

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

Erin E Gabriel, Michael P Fay, Sumana Chakravarty, 2017, The Lancet. Infectious diseases.

Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

Mario Roederer, Barney S. Graham, Sumana Chakravarty, 2013, Science.

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

Mario Roederer, Sumana Chakravarty, Martha C Nason, 2017, Proceedings of the National Academy of Sciences.

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Sumana Chakravarty, Joana C. Silva, S. Hoffman, 2017, JCI insight.

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Mario Roederer, Sumana Chakravarty, Martha C Nason, 2016, Nature Medicine.

Mechanisms of gene regulation in Plasmodium.

Manuel Llinás, Manoj Duraisingh, Shahid Khan, 2007, The American journal of tropical medicine and hygiene.

Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report

S. Hoffman, M. P. V. van Meer, R. Sauerwein, 2014, Malaria Journal.